These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21513498)

  • 1. Natural products as a source of protein kinase activators and inhibitors.
    Marston A
    Curr Top Med Chem; 2011; 11(11):1333-9. PubMed ID: 21513498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Recently Reported Marine Derived Natural Product Kinase Inhibitors.
    Li T; Wang N; Zhang T; Zhang B; Sajeevan TP; Joseph V; Armstrong L; He S; Yan X; Naman CB
    Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31450856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounds from Natural Sources as Protein Kinase Inhibitors.
    Baier A; Szyszka R
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33198400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
    Ebrahim HY; El Sayed KA
    Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery and development of natural products as Type II JAK2 inhibitors for the treatment of hepatitis C.
    Ma ED; Leung CH; Chiu P; Cheng YC
    Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):32-6. PubMed ID: 27390008
    [No Abstract]   [Full Text] [Related]  

  • 6. Plant Extracts and their Secondary Metabolites as Modulators of Kinases.
    Gill MSA; Saleem H; Ahemad N
    Curr Top Med Chem; 2020; 20(12):1093-1104. PubMed ID: 32091334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic identification of the druggable interactions between human protein kinases and naturally occurring compounds in endometriosis.
    Jiang L; Tang C; Rao J; Xue Q; Wu H; Wu D; Zhang A; Chen L; Shen Z; Lei L
    Comput Biol Chem; 2017 Dec; 71():136-143. PubMed ID: 29096379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery and the human kinome: recent trends.
    Eglen R; Reisine T
    Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products as important tyrosine kinase inhibitors.
    Yin B; Fang DM; Zhou XL; Gao F
    Eur J Med Chem; 2019 Nov; 182():111664. PubMed ID: 31494475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resorcylic acid lactones as the protein kinase inhibitors , naturally occuring toxins.
    Patocka J; Soukup O; Kuca K
    Mini Rev Med Chem; 2013 Nov; 13(13):1873-8. PubMed ID: 24070207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase profiling in early stage drug discovery: sorting things out.
    Defert O; Boland S
    Drug Discov Today Technol; 2015 Nov; 18():52-61. PubMed ID: 26723893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anchor-based classification and type-C inhibitors for tyrosine kinases.
    Hsu KC; Sung TY; Lin CT; Chiu YY; Hsu JT; Hung HC; Sun CM; Barve I; Chen WL; Huang WC; Huang CT; Chen CH; Yang JM
    Sci Rep; 2015 Jun; 5():10938. PubMed ID: 26077136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay.
    Ou T; Hou X; Guan S; Dai J; Han W; Li R; Wang W; Qu X; Zhang M
    Nat Prod Res; 2016 Jun; 30(11):1240-7. PubMed ID: 26166578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
    Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
    Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds.
    Singh H; Kumar R; Mazumder A
    J Asian Nat Prod Res; 2024 Jun; 26(6):663-680. PubMed ID: 38373215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors from marine sponges.
    Skropeta D; Pastro N; Zivanovic A
    Mar Drugs; 2011; 9(10):2131-2154. PubMed ID: 22073013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meridianins: marine-derived potent kinase inhibitors.
    Bharate SB; Yadav RR; Battula S; Vishwakarma RA
    Mini Rev Med Chem; 2012 Jun; 12(7):618-31. PubMed ID: 22512550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein.
    Yan B; Liu L; Huang S; Ren Y; Wang H; Yao Z; Li L; Chen S; Wang X; Zhang Z
    Chem Commun (Camb); 2017 Mar; 53(26):3637-3640. PubMed ID: 28267172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.